US Patent Issued to SHANGHAI CELLIVER BIOTECHNOLOGY, SHANGHAI CRYOWISE MEDICAL TECHNOLOGY on June 23 for "Methods for amplifying and differentiating pancreatic cells, and application thereof" (Chinese Inventor)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,660, issued on June 23, was assigned to SHANGHAI CELLIVER BIOTECHNOLOGY Co. LTD. (Shanghai) and SHANGHAI CRYOWISE MEDICAL TECHNOLOGY Co. LTD. (Shanghai).

"Methods for amplifying and differentiating pancreatic cells, and application thereof" was invented by Hongdan Zhang (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "An amplifying method of pancreatic cells is provided. The amplifying method includes performing digestion, resuspension, discontinuous density gradient centrifugation treatment and amplifying treatment sequentially. The mammalian pancreatic duct is used as the source of pancreatic precursor-like cells in the amplifying method, ...